Rituximab versus Cyclophosphamide for the Treatment of Connective Tissue Disease Associated Interstitial Lung Disease (RECITAL): A Multi-Centre Randomised Controlled Trial

Autor:	T.M. Maher, V. Tudor, P. Saunders, M. Gibbons, S. Fletcher, H. Parfrey, C.P. Denton, E. Renzoni, M. Kokosi, A.U. Wells, D. Ashby, M. Szigeti, P.L. Molyneaux
Rok vydání:	2022
Zdroj:	C93. CLINICAL TRIALS IN CHRONIC LUNG DISEASE.
DOI:	10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4779
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::8406584cef154ce060a6c03d9173a0e9 https://doi.org/10.1164/ajrccm-conference.2022.205.1_meetingabstracts.a4779 Zobrazit plný text záznamu